Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/4725
DC FieldValueLanguage
dc.contributor.authorCini, Renzoen_us
dc.contributor.authorTamasi, Gabriellaen_us
dc.contributor.authorDefazio, Sandraen_us
dc.contributor.authorCorsini, Maddalenaen_us
dc.contributor.authorZanello, Pieroen_us
dc.contributor.authorMessori, Luigien_us
dc.contributor.authorMarcon, Giordanaen_us
dc.contributor.authorPiccioli, Francescaen_us
dc.contributor.authorOrioli, Pierluigien_us
dc.date.accessioned2021-03-30T15:44:16Z-
dc.date.available2021-03-30T15:44:16Z-
dc.date.issued2003-
dc.identifier.issn0020-1669en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/4725-
dc.description121007en_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofINORGANIC CHEMISTRYen_US
dc.subjectAntineoplastic Agents; Cell Survival; Crystallography, X-Ray; Drug Stability; Female; Humans; Inhibitory Concentration 50; Ligands; Models, Molecular; Molecular Structure; Organometallic Compounds; Ovarian Neoplasms; Oxidation-Reduction; Photochemistry; Pyrimidines; Ruthenium; Stereoisomerism; Tumor Cells, Cultured; Physical and Theoretical Chemistry; Inorganic Chemistryen_US
dc.titleStudy of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agentsen_US
dc.typeArticleen_US
dc.identifier.doi10.1021/ic0349095en_US
dc.identifier.pmid14632524en_US
dc.identifier.scopus2-s2.0-0344154620en_US
dc.identifier.isiWOS:000186833900051en_US
dc.relation.volume42en_US
dc.relation.issue24en_US
dc.description.firstpage8038en_US
dc.description.lastpage8052en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
crisitem.author.orcid0000-0002-6796-8863-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.